Answers are grounded in this paper and cite their sources.
Demonstrates effective ctDNA monitoring in uveal melanoma, suggesting broader applicability for treatment.
= 11), further supporting the accuracy of the multiplex assays. Our mutation-agnostic multiplex drop-off ddPCR assays provide a sensitive, specific, and cost-effective alternative to targeted NGS and simplex ddPCR for ctDNA monitoring in UM. By minimizing reliance on prior knowledge of tumor genotype with NGS, these assays enable broader clinical applicability for real-time treatment monitoring in UM.
No takes yet. Share an insight, caveat, or question.
Rampanou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: